Transmedics develops and offers medical technology products that focus on organ transplantation, specifically through the Organ Care System.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

COM:TRANSMEDICS

Transmedics

Last Close

84.97

05/11 18:19

Market Cap

4.56B

Beta: -

Volume Today

531.60K

Avg: -

locale

market

industry

website

ipo date

peer of

competitor of

Metrics